Guardant Health Appoints Kevin Sayer to Board
Guardant Health appointed former Dexcom CEO Kevin Sayer to its board.
Related stories
Mitsui Chemicals Shares Fall 10.12%
M impact | EQUITY | Nov 04, 2026, 12:51 AM UTC
SK Telecom Reports KRW411.80B Third-Quarter Net Profit
SK Telecom reported third-quarter net profit of KRW411.80 billion, versus a loss of KRW166.70 billion.
M impact | EQUITY | Nov 04, 2026, 12:49 AM UTC
SK Telecom Reports Third-Quarter Operating Profit of KRW552.30B
SK Telecom reported third-quarter operating profit of KRW552.30B, compared with KRW48.40B in the comparison period.
M impact | EQUITY | Nov 04, 2026, 12:48 AM UTC
Mitsui Chemicals shares extend decline, down 8.19%
M impact | EQUITY | Nov 04, 2026, 12:47 AM UTC
Mitsui Chemicals Shares Fall 8%
M impact | EQUITY | Nov 04, 2026, 12:47 AM UTC
HSBC issues bonds in two tranches
HSBC said it issued two tranches of senior unsecured bonds due in 2032 and 2037.
M impact | EQUITY | Nov 04, 2026, 12:44 AM UTC